Descartes-25 in Relapsed/Refractory Multiple Myeloma

NCT05113342 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Phase 1 enrollment completed. Further clinical development terminated.

Conditions

Multiple Myeloma
Relapse Multiple Myeloma

Interventions

DRUG: Descartes-25

Sponsor

Cartesian Therapeutics